Patent US4166108A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4166108A Expired / Lapsed US ⏱️ 0.0 years remaining

Styptic composition

Assignee: Individual
•
Filing: 1977-08-18
•
Granted: 1979-08-28
•
Expires: 1997-08-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved styptic composition which effectively curtails bleeding while administering a soothing sensation on the injured area. The styptic composition is in the form of a stable lotion or cream having the following general formula: (1) from about 2% to about 12% by weight of a long chain fatty acid; (2) from about 0.4% to about 3.5% by weight of a wax filler; (3) from about 1% to about 10% by weight of polyethylene glycol stearate; (4) from about 1% to about 5% by weight of polyethylene glycol sorbitan beeswax; and, (5) from about 0.5% to about 25% by weight of an acidic metallic salt, (6) the balance being water. Optionally, from about 1% to about 4% by weight of glycerin may be added as a humectant. Any conventional antiseptic may also be added to the composition. The styptic composition may be packaged in any convenient form including jars, bottles, tubes, pump applicators, aerosol canisters and can also be impregnated into pre-packaged bandages.

Inventors

  • 👤 Robert Brown
  • 👤 Jerome Setloff

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 05:47
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/06; A61K8/00; A61K8/18; A61K8/19; A61K8/26; A61K8/30; A61K8/33; A61K8/36; A61K8/361; A61K8/49; A61K8/4993; A61K8/92; A61K8/927; A61Q; A61Q15/00; A61Q19/00; A61K2800/00; A61K2800/74; A61K2800/75; A61L; A61L2400/00; A61L2400/04; Y; Y10; Y10S; Y10S424/00; Y10S424/05

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 190 words
A non-sting styptic composition as a stable cream or lotion comprising: (1) from about 2% to about 12% by weight of a saturated or unsaturated long chain fatty acid having from nine to twenty-three carbon atoms therein and selected from the group consisting of oleic acid, lauric acid, palmitic acid and stearic acid; (2) from about 0.4% to about 3.5% by weight of a wax filler selected from the group consisting of microcrystalline wax, paraffin wax and beeswax; (3) from about 1% to about 10% by weight of polyethylene glycol stearate; (4) from about 1% to about 5% by weight of polyethylene glycol (20) sorbitan beeswax; and, (5) from about 0.5% to about 25% by weight of an acidic metallic salt selected from the group consisting of aluminum chloride, aluminum sulfate, aluminum chlorohydrate, aluminum amonium sulfate, aluminum potassium sulfate, zinc chloride, zinc sulfate, zinc chlorohydrate, ferric chloride, ferric sulfate, ferric chlorohydrate and combinations thereof, said acidic metallic salt being characterized by possessing a degree of acidity sufficient to stanch the flow of blood and being capable of being formulated into said stable cream or lotion, (6) the balance being water.
Claim 2
Dependent Claim 190 words
A non-sting styptic composition as a stable cream or lotion comprising: (1) from about 2% to about 12% by weight of a saturated or unsaturated long chain fatty acid having from nine to twenty-three carbon atoms therein and selected from the group consisting of oleic acid, lauric acid, palmitic acid and stearic acid; (2) from about 0.4% to about 3.5% by weight of a wax filler selected from the group consisting of microcrystalline wax, paraffin wax and beeswax; (3) from about 1% to about 10% by weight of polyethylene glycol stearate; (4) from about 1% to about 5% by weight of polyethylene glycol (20) sorbitan beeswax; and, (5) from about 0.5% to about 25% by weight of an acidic metallic salt selected from the group consisting of aluminum chloride, aluminum sulfate, aluminum chlorohydrate, aluminum amonium sulfate, aluminum potassium sulfate, zinc chloride, zinc sulfate, zinc chlorohydrate, ferric chloride, ferric sulfate, ferric chlorohydrate and combinations thereof, said acidic metallic salt being characterized by possessing a degree of acidity sufficient to stanch the flow of blood and being capable of being formulated into said stable cream or lotion, (6) the balance being water.
Claim 3
Dependent Claim 27 words
The styptic composition of claim 1, wherein the acidic metallic salt is selected from the group consisting of aluminum sulfate, aluminum potassium sulfate and aluminum ammonium sulfate.
Claim 4
Dependent Claim 14 words
The styptic composition of claim 2, wherein the acidic metallic salt is aluminum sulfate.
Claim 5
Dependent Claim 12 words
The styptic composition of claim 3, wherein the wax filler is beeswax.
Claim 6
Dependent Claim 15 words
The styptic composition of claim 4, wherein the long chain fatty acid is stearic acid.
Claim 7
Dependent Claim 23 words
The styptic composition of claim 1, wherein a humectant is present in an amount ranging from about 1% to about 4% by weight.
Claim 8
Dependent Claim 11 words
The styptic composition of claim 6, wherein the humectant is glycerin.
Claim 9
Dependent Claim 9 words
The styptic composition of claim 6 including an antiseptic.
Claim 10
Dependent Claim 17 words
The non-sting styptic composition of claim 8 wherein said composition is contained in a pressurized aerosol container.
Claim 11
Dependent Claim 36 words
The non-sting styptic composition of claim 8 wherein said composition is included with a bandage having a wound covering area composed of fibers selected from the group consisting of natural fibers, man-made fibers and mixtures thereof.
Claim 12
Dependent Claim 17 words
The non-sting styptic composition of claim 1 wherein said composition is contained in a pressurized aerosol container.
Claim 13
Dependent Claim 36 words
The non-sting styptic composition of claim 1 wherein said composition is included with a bandage having a wound covering area composed of fibers selected from the group consisting of natural fibers, man-made fibers and mixtures thereof.

References Cited (Backward Citations)

US2492085A Cited
US3235458A Cited
US3343540A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-08-27 1983-02-26 1983-08-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-08-27 1987-02-26 1987-08-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-08-27 1991-02-26 1991-08-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag